A critical advance in cancer investigation is arising with the use of nanobodies to re-engage mutated p53. This vital malignant inhibitor protein is frequently lost in several types of tumors, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research